You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CDX0159-05

Showing 1 - 25 of 398
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Subjects Trial in Lincoln (CDX-0159, Normal saline)

Completed
  • Healthy Subjects
  • Lincoln, Nebraska
    Celerion, Inc
Jan 20, 2022

Cold Urticaria, Cold Contact Urticaria, Symptomatic Dermographism Trial in Berlin (CDX-0159)

Active, not recruiting
  • Cold Urticaria
  • +4 more
  • Berlin, Germany
    Charite University
Dec 20, 2022

Chronic Spontaneous Urticaria Trial in Germany, United States (CDX-0159, Normal Saline)

Completed
  • Chronic Spontaneous Urticaria
  • Birmingham, Alabama
  • +13 more
Jan 24, 2023

Eosinophilic Esophagitis Trial (barzolvolimab, Matching Placebo)

Not yet recruiting
  • Eosinophilic Esophagitis
  • barzolvolimab
  • Matching Placebo
  • (no location specified)
Mar 7, 2023

Prurigo Nodularis Trial in Germany, United States (CDX-0159, Normal saline)

Recruiting
  • Prurigo Nodularis
  • CDX-0159
  • Normal saline
  • Tempe, Arizona
  • +18 more
Jan 4, 2023

Chronic Spontaneous Urticaria Trial in Hungary, United States (barzolvolimab, Matching Placebo)

Recruiting
  • Chronic Spontaneous Urticaria
  • barzolvolimab
  • Matching Placebo
  • Birmingham, Alabama
  • +44 more
Dec 8, 2022

Chronic Inducible Urticaria Trial in United States (barzolvolimab, Matching Placebo)

Recruiting
  • Chronic Inducible Urticaria
  • barzolvolimab
  • Matching Placebo
  • Birmingham, Alabama
  • +31 more
Jan 20, 2023

Healthy Subjects Trial in Overland Park (CDX-0159, Normal saline)

Completed
  • Healthy Subjects
  • Overland Park, Kansas
    Altasciences Clinical Kansas, Inc.
Jul 2, 2020

Lung Infection, Pneumonia, Ventilator-Associated, Infection, Bacterial Trial in Worldwide (AR-301, Placebo)

Recruiting
  • Lung Infection
  • +3 more
  • Sacramento, California
  • +139 more
Feb 25, 2022

Chronic Troublesome Sialorrhea, Cerebral Palsy, Stroke Trial in Worldwide (NT 201 Placebo, NT 201)

Completed
Has Results
  • Chronic Troublesome Sialorrhea
  • +4 more
  • NT 201 Placebo
  • NT 201
  • Kobuleti, Georgia
  • +30 more
Aug 6, 2021

Breast Cancer, Breast Tumors, HER2-positive Breast Cancer Trial in Worldwide (TX05 (trastuzumab), Herceptin®, Paclitaxel)

Completed
Has Results
  • Breast Cancer
  • +4 more
  • TX05 (trastuzumab)
  • +4 more
  • Lesnoy, Minsk Region, Belarus
  • +145 more
Jan 7, 2022

HLA-DQA1*05 Genotype in Anti-TNF Treatment With Proactive

Recruiting
  • Drug Monitoring
  • Inflammatory Bowel Diseases
  • Tumor necrosis factor (TNF)-alpha inhibitors
  • Valladolid, Spain
    Hospital Universitario Rio Hortega
Aug 8, 2023

Treatment Resistant Depression, MDD Trial in United States (AXS-05, Placebo)

Completed
  • Treatment Resistant Depression
  • Major Depressive Disorder
  • Little Rock, Arkansas
  • +19 more
Jul 8, 2022

Crohn Disease, Infliximab Trial (Azathioprine, Infliximab)

Not yet recruiting
  • Crohn Disease
  • Infliximab
  • (no location specified)
Apr 3, 2023

Healthy Trial in Overland Park (TP-05 (lotilaner oral), fasted group, TP-05 (lotilaner oral), high-fat group, TP-05 (lotilaner

Active, not recruiting
  • Healthy
  • TP-05 (lotilaner oral), fasted group
  • +2 more
  • Overland Park, Kansas
    Dr. Vince Clinical Research
Feb 14, 2023

MDD, Treatment Resistant Depression, Depression Trial in United States (AXS-05)

Completed
Has Results
  • Major Depressive Disorder
  • +2 more
  • AXS-05 (dextromethorphan and bupropion) oral tablets
  • Phoenix, Arizona
  • +50 more
Sep 16, 2022

Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer, Agitation Trial in United States (AXS-05, Placebo)

Recruiting
  • Agitation in Patients With Dementia of the Alzheimer's Type
  • +2 more
  • Peoria, Arizona
  • +22 more
Dec 12, 2022

Rheumatoid Arthritis Trial in Worldwide (PF-06650833, PF-06651600, Tofacitinib)

Completed
  • Rheumatoid Arthritis
  • Pleven, Bulgaria
  • +143 more
Mar 2, 2022

Healthy Volunteer Trial (Low Dose TP-05, High Dose TP-05, Placebo Comparator)

Recruiting
  • Healthy Volunteer
  • Low Dose TP-05
  • +2 more
  • Boston, Massachusetts
    Tufts University School of Medicine
Jan 5, 2023

Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer, Agitation, Psychomotor Trial in United States (AXS-05

Enrolling by invitation
  • Agitation in Patients With Dementia of the Alzheimer's Type
  • +2 more
  • AXS-05 (dextromethorphan-bupropion)
  • Lafayette, California
  • +26 more
Sep 29, 2022

2D and 3D Primary Cell Cultures From Gastric and

Not yet recruiting
  • Gastric and Gastroesophageal Junction Cancer
    • Berlin, Germany
      Department of Anesthesiology and Operative Intensive Care Medici
    Sep 13, 2022

    Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer, Agitation,Psychomotor Trial in Canada, United States

    Completed
    • Agitation in Patients With Dementia of the Alzheimer's Type
    • +2 more
    • Sun City, Arizona
    • +62 more
    Dec 13, 2022

    Advanced Melanoma Trial in New York, Houston (LTX-315 in combination with pembrolizumab)

    Recruiting
    • Advanced Melanoma
    • LTX-315 in combination with pembrolizumab
    • New York, New York
    • +7 more
    Jan 23, 2023

    Healthy Trial in Overland Park (TP-05 (lotilaner oral capsules), Placebo)

    Completed
    • Healthy
    • TP-05 (lotilaner oral capsules)
    • Placebo
    • Overland Park, Kansas
      Altasciences
    Aug 1, 2022

    How do Perceptions of Coronavirus Disease Risk Influence Health

    Recruiting
    • Pregnancy Related
      • Vancouver, British Columbia, Canada
      • +1 more
      Jan 9, 2023